Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
about
Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalVitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinomaCorrelation Between Tumor Regression Grade and Clinicopathological Parameters in Patients With Squamous Cell Carcinoma of the Esophagus Who Received Neoadjuvant Chemoradiotherapy.Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.Accomplishments in 2008 in the management of esophageal cancerHistologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer.Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?1,25-dihydroxyvitamin D in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.The prognostic value of metastatic lymph node number and ratio in oesophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation.Update: modern approaches to the treatment of localized esophageal cancer.A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.Efficacy and safety of chemoradiation therapy compared with chemotherapy for esophageal carcinoma: An updated meta-analysis of randomized controlled trials.Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy.Nodal Metastasis From Locally Advanced Esophageal Cancer: How Neoadjuvant Therapy Modifies Their Frequency and Distribution
P2860
Q26798220-A6A455F7-BFC7-48B2-BD85-B0B79E24D86DQ36105064-9D7C9AD2-E2F9-467A-9B39-542E0E2D3AD7Q36153225-BEBB7A08-AA48-4679-BCCB-4158B1E4F5A4Q37439912-D21139A9-F957-42D4-B4AD-9AEAF9616290Q37468864-CDB2CE3F-3BAA-4E0E-BC2B-1A6FA231E5FEQ37658761-955501CB-18CE-4391-85B4-DB20A7404EA3Q38031599-6F5ED534-18F1-4AE0-8F77-F06C8C0A594FQ38111420-30610366-CA21-4E6C-B38C-3C70FEA987F5Q40900360-9D4FBA94-D143-48F4-AC43-EB78E2930675Q42011346-42BE23EF-7A57-4A9C-B241-6293BAC3BD6CQ45716440-8249A96B-36BE-4460-8B7C-13DB20B2CE0DQ47106949-8C0191F3-0E13-4546-A66D-8F6D82A13A92Q47146363-495A425B-C630-4950-8233-4A7D0AFC58A7Q47296527-29271B8B-0714-4D86-B011-C31B20A46F18Q56914044-C716B019-E768-4EAC-A47E-EB9026E635B0
P2860
Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Refining esophageal cancer sta ...... ortance of treatment response.
@en
Refining esophageal cancer sta ...... ortance of treatment response.
@nl
type
label
Refining esophageal cancer sta ...... ortance of treatment response.
@en
Refining esophageal cancer sta ...... ortance of treatment response.
@nl
prefLabel
Refining esophageal cancer sta ...... ortance of treatment response.
@en
Refining esophageal cancer sta ...... ortance of treatment response.
@nl
P2093
P50
P1476
Refining esophageal cancer sta ...... portance of treatment response
@en
P2093
Andrew P Barbour
Bryan Burmeister
Damien B Thomson
Janine Thomas
Mithat Gonen
P2888
P304
P356
10.1245/S10434-008-0084-Y
P577
2008-07-29T00:00:00Z
P6179
1047765577